Modeling and simulation to adjust p values in presence of a regression to the mean effect

American Statistician

Volumn 61, Issue 4, 2007, Pages 302-307

  Krause, Andreas ^a,b   Pinheiro, José ^b  

^a PHARSIGHT CORPORATION   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Modeling; P value adjustment; Posterior predictive check; Retrospective analysis; Simulation; Subgroup analysis

Indexed keywords

EID: 36649010927     PISSN: 00031305     EISSN: None     Source Type: Journal    
DOI: 10.1198/000313007X245023     Document Type: Article

References (15)

1. Barnett, A. G., van der Pols, J. C., and Dobson, A. J. (2004), "Regression to the Mean: What It is and How to Deal With It," International Journal of Epidemiology, 34, 215-220.
2. Chen, S. D., Cox, C., et al. (1998), "A More Flexible Regression-to-the-Mean Model with Possible Stratification," Biometrics, 54, 939-947.
3. Corey-Bloom, J. R., Anand, J. V., and Veach, J. (1998), "A Randomized Trial Evaluating the Efficacy and Safety of ENA 713 (rivastigmine tartrate), a New Acetylcholinesterase Inhibitor, in Patients with Mild to Moderately Severe Alzheimer's Disease," International Journal of Geriatric Psychopharmacology, 1, 55-65.
4. Efron, B., and Tibishirani, R.J. (1994), An Introduction to the Bootstrap, New York: Chapman & Hall/CRC.
5. Farlow, M. R., Small, G. W., Quarg, P., and Krause A. (2005), "Efficacy of Rivastigmine in Alzheimer's Disease Patients with Rapid Disease Progression: Results of a Meta-analysis," Dementia and Geriatric Cognitive Disorders, 20, 192-197.
6. Galton, F. (1886), "Regression Towards Mediocrity in Hereditary Stature," Journal of the Anthropological Institute, 15, 246-263.
7. Gelman, A., Meng, X.-L., and Stern, H. (1996), "Posterior Predictive Assessment of Model Fitness via Realized Discrepancies," Statistica Sinica, 6, 733-807.
8. Gelman, A., Carlin, J.B., Stern, H.S., and Rubin, D.B. (2004), Bayesian Data Analysis, Boca Raton, FL: Chapman & Hall/CRC.
9. Lin, H. M., and Hughes, M. D. (1997), "Assessing the Effects of Interventions using Longitudinal Data with Samples Subject to Selection," Biometrics, 53, 924-936.
10. Rösler, M., Anand, R., et. al. (1999), "Efficacy and Safety of Rivastigmine in Patients With Alzheimer's Disease: International Randomized Controlled Trial," BMJ, 318, 633-640.
11. Schneider, A., Anand, R., and Farlow, M. (1998), "Systematic Review of the Efficacy of Rivastigmine for Patients with Alzheimer's Disease," International Journal of Geriatric Rsychopharmacology, 1, 26-34.
12. Senn, S. J., and R. A. Brown (1985), "Estimating Treatment Effects in Clinical Trials Subject to Regression to the Mean," Biometrics, 41, 555-560.
13. _ (1989), "Maximum Likelihood Estimation of Treatment Effects for Samples Subject to Regression to the Mean," Communications in Statistics - Theory and Methods, 18, 3389-3406
14. Tusher, V. G., Tibshirani, R., and Chu, G. (2001), "Significance Analysis of Microarrays Applied to the Ionizing Radiation Response," PNAS, 98(9), 5116-5121.
15. Westfall, P.H., and Young, S.S. (1993), Resampling-Based Multiple Testing: Examples and Methods for p-value Adjustment, New York: Wiley.